48
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Vidarabine and 2-Deoxycoformycin as Antileukemic Agents Against Monocytic Leukemia

&
Pages 57-66 | Received 24 Dec 1999, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nikolas Herold, Sean G. Rudd, Kumar Sanjiv, Juliane Kutzner, Julia Bladh, Cynthia B. J. Paulin, Thomas Helleday, Jan-Inge Henter & Torsten Schaller. (2017) SAMHD1 protects cancer cells from various nucleoside-based antimetabolites. Cell Cycle 16:11, pages 1029-1038.
Read now

Articles from other publishers (5)

Jianjian Zhuang, Liping Xia, Zheyu Zou & Juxin Yin. (2022) Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells. Medical Oncology 39:5.
Crossref
Raghu Ningegowda, Amit Grover, Basappa, S. Ranjith, Kanchugarakoppal S. Rangappa, B. S. Priya & S. Nanjunda Swamy. (2009) Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivatives. Investigational New Drugs 28:6, pages 754-765.
Crossref
Katarzyna Bednarska, Agnieszka B. Olejniczak, Błażej A. Wojtczak, Zofia Sułowska & Zbigniew J. Leśnikowski. (2010) Adenosine and 2′-Deoxyadenosine Modified with Boron Cluster Pharmacophores as New Classes of Human Blood Platelet Function Modulators. ChemMedChem 5:5, pages 749-756.
Crossref
Hellinida Thomadaki, Chris Milto Tsiapalis & Andreas Scorilas. (2007) The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemotherapy and Pharmacology 61:4, pages 703-711.
Crossref
. (2001) Current Awareness. Hematological Oncology 19:1, pages 35-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.